Inferences of carboplatin response-related signature by integrating multiomics data in ovarian serous cystadenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Experimental Biology and Medicine"
DOI: 10.1177/15353702221083254
Abstract: Platinum-based chemotherapy, especially carboplatin, is the primary measure to treat patients with ovarian cancer (OC). However, OC patients still have an adverse prognosis due to emergency of chemotherapy resistance. Ovarian serous cystadenocarcinoma (OSC) is the… read more here.
Keywords: carboplatin response; signature; serous cystadenocarcinoma; resistance ... See more keywords